Previous Article | Next Article 
Molecular and Cellular Biology, April 2001, p. 2918-2932, Vol. 21, No. 8
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.21.8.2918-2932.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
RBP1 Recruits the mSIN3-Histone Deacetylase Complex to the Pocket
of Retinoblastoma Tumor Suppressor Family Proteins Found in Limited
Discrete Regions of the Nucleus at Growth Arrest
Albert
Lai,1
Brian K.
Kennedy,2
David A.
Barbie,2
Nicholas R.
Bertos,3
Xiang Jiao
Yang,3
Marie-Christine
Theberge,1
Shih-Chang
Tsai,4
Edward
Seto,4
Yi
Zhang,5
Andrei
Kuzmichev,6
William S.
Lane,7
Danny
Reinberg,6
Ed
Harlow,2 and
Philip E.
Branton1,8,*
Departments of Biochemistry1 and
Oncology8 and Molecular Oncology
Group, Department of Medicine,3 McGill
University, Montreal, Quebec, Canada H3G 1Y6; MGH Cancer
Center, Charlestown, Massachusetts 021292;
Howard Hughes Medical Institute, Division of Nucleic Acids
Enzymology, Department of Biochemistry, University of Medicine and
Dentistry of New Jersey, Robert Wood Johnson Medical School,
Piscataway, New Jersey 088546;
Lineberger Comprehensive Cancer Center, Department of
Biochemistry and Biophysics, University of North Carolina at Chapel
Hill, Chapel Hill, North Carolina 27599-72955;
H. Lee Moffitt Cancer Center and Research Institute,
Molecular Oncology Program, University of South Florida, Tampa,
Florida 336124; and Harvard
Microchemistry Facility, Harvard University, Cambridge,
Massachusetts 021387
Received 31 August 2000/Returned for modification 11 October
2000/Accepted 16 January 2001
 |
ABSTRACT |
Retinoblastoma (RB) tumor suppressor family pocket proteins induce
cell cycle arrest by repressing transcription of E2F-regulated genes
through both histone deacetylase (HDAC)-dependent and -independent mechanisms. In this study we have identified a stable complex that
accounts for the recruitment of both repression activities to the
pocket. One component of this complex is RBP1, a known pocket-binding
protein that exhibits both HDAC-dependent and -independent repression
functions. RB family proteins were shown to associate via the pocket
with previously identified mSIN3-SAP30-HDAC complexes containing
exclusively class I HDACs. Such enzymes do not interact directly with
RB family proteins but rather utilize RBP1 to target the pocket. This
mechanism was shown to account for the majority of RB-associated HDAC
activity. We also show that in quiescent normal human cells this entire
RBP1-mSIN3-SAP30-HDAC complex colocalizes with both RB family members
and E2F4 in a limited number of discrete regions of the nucleus that in
other studies have been shown to represent the initial origins of DNA
replication following growth stimulation. These results suggest that RB
family members, at least in part, drive exit from the cell cycle by
recruitment of this HDAC complex via RBP1 to repress transcription from
E2F-dependent promoters and possibly to alter chromatin structure at
DNA origins.
 |
INTRODUCTION |
The retinoblastoma (RB) tumor
suppressor gene product, pRB, regulates transcriptional events
important for cell proliferation (for reviews, see references 17
and 45). A major target of pRB is the E2F family of
transcription factors that control expression of many genes required
for DNA synthesis and cell cycle progression. Binding of pRB to E2F
species inhibits expression of E2F-regulated genes, resulting in
withdrawal from the cell cycle (for reviews, see references 3,
26, and 45). pRB and related pocket proteins p107 and p130
utilize multiple mechanisms to elicit this effect. With certain
promoters, binding via the pocket to the activation domain of E2F
inhibits E2F-mediated transactivation (23, 27, 28). But
this mechanism does not explain how, with other promoters, E2F binding
sites function as negative regulatory elements (13, 31, 47,
61). In these cases, RB family members function as
transcriptional repressors, which utilize E2F proteins as DNA-docking factors. Studies using pRB fused to heterologous DNA binding domains indicated that the pRB pocket functions as an active repressor (1, 7, 52, 61, 62). This repression function, and not
pRB-mediated inhibition of the E2F transactivation domain, was shown
recently to be required for G1 arrest triggered by
transforming growth factor
, p16INK4a, and
contact inhibition (67) and for blockage of the cell cycle by pRB (25, 52). Thus, active repression by RB family
members is important for exit from the cell cycle.
Several mechanisms have been proposed to account for repression by pRB.
Dean and coworkers suggested that the pocket might prevent
transactivators from interacting with components of the TFIID complex
(41, 61). Rose et al. proposed that E2F itself may be
affected in this way by the pocket (50). The pocket is now
known to interact simultaneously with E2F and other cellular factors,
and our work and that of others suggested that RB-binding proteins
might utilize conserved LXCXE motifs to recruit repression activities
to the pocket (6, 16, 20, 21, 31, 39, 40, 41, 42, 57, 62).
Some of the models proposed in these studies (6, 16, 41, 42,
57) stressed the importance of chromatin structure in regulating
transcriptional activity (for reviews, see references 4, 36, and
53). Active repression by pRB therefore could involve a
mechanism by which condensed chromatin structure is enhanced through
the creation of hypoacetylated histones or other target proteins.
Understanding of the enzyme complexes involved in histone acetylation
and deacetylation has increased greatly in recent years (for reviews
see references 2 and 37). The catalytic subunits (Rpd3,
HDA, and HOS) of histone deacetylase (HDAC) complexes from yeast were
cloned (8, 51), and several mammalian versions have now
been identified within two classes (14, 18, 44, 55, 60, 65,
66). HDAC1, HDAC2, and HDAC3 are class I enzymes that share
homology with yeast Rpd3, whereas HDAC4, HDAC5, HDAC6, and HDAC7 are
class II enzymes that share homology with yeast HDA1. At least two
distinct HDAC complexes (mSIN3-HDAC and NURD) were isolated in
mammalian cells (58, 59, 64, 68, 69, 70, 71). Both
complexes contain the class I HDACs, HDAC1 and HDAC2. Most of the
subunits in the NURD and mSIN3-HDAC complexes have now been identified.
Some subunits, like RBAP46, RBAP48, HDAC1, and HDAC2, are present in
both complexes; however, the majority of subunits in these complexes
are distinct. The NURD complex contains an ATPase subunit, Mi2, MTA2,
and MBD3, whereas the mSIN3 contains the mSIN3A/B, SAP30, and SAP18
components (2, 64, 68, 69, 70, 71). The mSIN3-HDAC
complexes are recruited by many transcriptional repressors in a pattern
evolutionarily conserved from yeasts to humans (32, 54,
71). In contrast to the mSIN3-HDAC complex, the NURD complex is
able to deacetylate nucleosomal templates, and it is recruited to
methylated DNA, suggesting a role in gene silencing by DNA methylation
(46, 59, 69).
The pocket domains of RB family members were shown not long ago to
repress E2F-dependent transcription by recruiting HDAC1, HDAC2, and
HDAC3 (5, 6, 39, 41, 42). These results suggested that
HDACs are important for the active repression function of RB family
members. However, drug inhibition studies by our group and others
indicated that both HDAC-dependent and -independent activities function
at the pocket simultaneously, suggesting that other components are also
involved with active repression by RB family proteins (39,
41).
We have previously demonstrated that an LXCXE-containing RB-binding
protein, RBP1, functions as an adapter protein by recruiting class I
HDACs to the pocket. In addition, RBP1 possesses an HDAC-independent repression activity. Therefore, the recruitment of RBP1 to the pocket
provides a model that explains both HDAC-dependent and -independent
repression by RB family members (39, 40). Furthermore, it
has recently been suggested that RBP1 is present as a component of the
mSIN3-HDAC complex (D. Reinberg, unpublished data). In this report, we
present evidence that HDAC activity present in the mSIN3-HDAC complex
is recruited to RB family members via RBP1 and not via a direct
interaction between the pocket and an IXCXE motif found in HDAC1 and
HDAC2, as suggested previously (6, 21, 41, 42). We further
demonstrate the physiological importance of the recruitment of the
mSIN3-HDAC complex by RB family members in quiescent cells.
 |
MATERIALS AND METHODS |
Plasmids and antibodies.
Bacterial expression plasmids
expressing glutathione S-transferase (GST)-pRB
(379-928), GST-pRB(379-928-C706F), GST-p107(252-936), and
GST-p107(252-936-C713F) were gifts from Bill Kaelin and Mark Ewen
(19, 33). Plasmid constructs expressing GST-SAP30 and pET28-SAP30 for in vitro translation have been described before (71). pVZmSIN3B and pVZmSIN3A constructs for in vitro
translation were gifts from Bob Eisenman. pGEM-RbAp48 and
pcDNA3-Flag-HDAC1 plasmids used for in vitro translation were provided
by Eva Lee (49) and Ed Seto, respectively. Plasmids
expressing GST-HDAC1 and GST-HDAC3 have been described elsewhere
(56). All GST fusion proteins with various truncations of
RBP1, including GST-R1, GST-R2, GST-ARID, GST-dl1208C, and GST-dl747C,
were generated by subcloning cDNAs from the Gal4 fusion mammalian
expression plasmids expressing the corresponding mutants
(39) into plasmid pGEX-2TK. Plasmid expressing GST-E1A in
bacteria was described before (39).
Monoclonal antibodies against RBP1 used in coimmunoprecipitation and
immunofluorescence studies (LY11, LY32, and LY48) were gifts from Bill
Kaelin and Jim DeCaprio. LY11 and LY32 have been described previously
(39, 40). Amino-terminal RBP1 polyclonal antiserum was
produced commercially by injecting an amino-terminal RBP1 peptide
(CLKQDNTTQLVQDDQVKGPLRV) into rabbits (Genemed Synthesis Inc.). Monoclonal antibody NM11 against p300 was kindly provided by
Betty Moran (12). Antibodies against pRB purchased
commercially included XZ91 and G3-245 (Pharmingen), IF8 (Santa Cruz
Biotechnology), and polyclonal C-15 (Santa Cruz); monoclonal antibody
C36 was obtained from Ed Harlow. Rabbit polyclonal antibodies against HDAC1, HDAC2, and HDAC3 were described previously, and goat polyclonal antibodies against HDAC1 (C-19) and HDAC2 (C-19) were purchased from
Santa Cruz. Monoclonal antibody 15G12 against RBAP46/48 (GeneTex) and
polyclonal antibodies AK11 and AK12 against mSIN3A and mSIN3B, respectively, were purchased from Santa Cruz. Rabbit polyclonal antibody against SAP30 has been described elsewhere (71).
Finally, monoclonal antibody against the His6 epitope was
purchased commercially (Amersham Pharmacia).
Purification of His6-tagged and GST
fusion proteins.
His6-tagged HDAC1, HDAC2, and HDAC3
proteins were purified from SF9 insect cells infected with baculovirus
expressing these proteins under a constitutive promoter (a gift from Ed
Seto and Yi Zhang). All GST fusion proteins and His-SAP30 were purified from Escherichia coli BL21-DE3. Competent bacterial cells
were transformed with pGEX-2TK plasmids containing cDNAs encoding
appropriate proteins. Transformed cells were grown in 2YT medium at
30°C with agitation until the optical density at 595 nm reached 1.2. Isopropyl-
-D-thiogalactopyranoside (50 mg/liter, final
concentration) was used to induce expression of GST fusion proteins for
another 1.5 h. Cells were harvested and lysed by sonication in
buffer B (50 mM Tris-HCl [pH 7.5] containing 200 mM NaCl, 5 mM EDTA,
10 mM mercaptoethanol, 1% [vol/vol] Triton X-100, and 1 mM protease
inhibitor cocktail). GST fusion proteins were isolated from extracts by
incubation with 1 ml of glutathione-Sepharose 4B (Pharmacia) per liter
for 2 to 4 h. Proteins bound to beads were washed six times with
buffer B and eluted by incubation with 20 mM reduced glutathione
(Sigma). Eluted proteins were spin dialyzed and concentrated by
Centricon spin columns (Millipore). Concentrations of purified proteins
were determined by standard Bradford assays.
In vitro binding assays.
mSIN3A, mSIN3B, RBAP48, HDAC1,
SAP30, and luciferase proteins were labeled and synthesized in the
presence of [35S]methionine protein labeling mix (NEN)
using the TnT coupled reticulocyte lysate system (Promega).
Three-microgram aliquots of GST fusion proteins purified from bacteria
were incubated with 5 µl of in vitro-translated proteins with 10 µl
of glutathione-Sepharose 4B beads (Pharmacia) in 1 ml of buffer A (1×
phosphate-buffered saline, 0.1% NP-40, 1 mM aprotinin, 1 mM leupeptin,
1 mM pepstatin) for 2 h at 4°C. GST pull-down assays were
performed using six washes, and the resulting proteins associated with
the beads were eluted with 2X sample buffer. Samples were resolved by
sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) using gels containing 10% polyacrylamide. Gels were fixed by dimethyl sulfoxide-2,5-diphenyloxazole treatment and then dried and analyzed by
autoradiography using Kodak X-Omat film. In vitro binding assays using
purified His6-tagged proteins were performed similarly, except that instead of in vitro-translated proteins, 3-µg aliquots of
His6-tagged proteins were incubated with 3 µg of GST
fusion proteins. GST pull-down assays were performed, and the samples were resolved by SDS-PAGE using 10% polyacrylamide gels. Proteins were
then transferred to polyvinylidene difluoride membranes (Millipore), which were probed with anti-His6 monoclonal antibody
(Amersham Pharmacia) and then by horseradish peroxidase-conjugated goat anti-mouse secondary antibody (Jackson Laboratories). Binding was
detected by enhanced Luminol reagent (NEN Life Science).
HDAC assays.
Three-microgram aliquots of GST proteins
purified from bacteria were incubated with H1299 cell nuclear extracts
in 10 µl of glutathione-Sepharose 4B beads (Pharmacia). GST pull-down
assays were performed, and the resulting beads were incubated with
10,000 cpm of 3H-labeled histones extracted from HeLa
cells, as described previously (60), in 0.1 ml of buffer H
(50 mM Tris-HCl [pH 7.5] containing 100 mM NaCl, 0.1 mM EDTA, and 0.1 mM phenylmethylsulfonyl fluoride). The reaction mixtures were incubated
at 37°C for 2 h, and reactions were stopped by the addition of
50 µl of 0.1 M HCl-0.16 M acetic acid solution. Then 0.5 ml of ethyl
acetate was used to extract [3H]acetate. The resulting
mixtures were separated into aqueous and organic phases by
centrifugation, and 0.4 ml of the upper organic phase was quantified by
scintillation counting.
Immunodepletion.
Lysates from one half of a 150-mm-diameter
plate of H1299 cells were incubated with 5 to 10 µl of antibody in 10 µl of protein G- or protein A-Sepharose in buffer A containing 1 µM
protease inhibitor cocktail for 4 h at 4°C. Immunoprecipitated
proteins were washed six times with buffer A and subjected to HDAC
assays to detect HDAC activity. The remaining lysates were subjected to
another round of immunoprecipitation using the same quantity of
antibodies and fresh protease inhibitor cocktails. Between 7 to 10 rounds of immunodepletion were performed until background levels of
HDAC activity were detected. Such lysates were incubated with 100 µl
of Pansorbin cells (Calbiochem) for another 4 h at 4°C to remove
excess antibodies. These extracts were used to detect associated HDAC activity.
In vivo binding assays.
H1299 cells were cultured,
harvested, and lysed as described before (39). Five to 10 µl of antibody against different endogenous proteins was used to
perform immunoprecipitations using lysates from 150-mm-diameter plates
of cells. Immunoprecipitation was performed at 4°C for 12 h, and
samples were washed and eluted as described previously
(39). Associating proteins were detected by Western blot
analysis using appropriate antibodies.
Immunofluorescence.
WI38 cells were seeded on plates
containing coverslips and serum-starved in Dulbecco modified Eagle
medium containing 0.1% fetal bovine serum for 72 h. Cells were
incubated with cell proliferation labeling reagents containing
bromodeoxyuridine (BrdU) and fluorodeoxyuridine (Amersham), fixed in
4% paraformaldehyde, and permeabilized in 1× phosphate-buffered
saline containing 0.5% Triton X-100. Indirect immunofluorescence was
performed using a monoclonal antibody against BrdU (Amersham).
Fluorescein- or Texas red-conjugated secondary antibodies (Vector
Laboratories) were used to detect BrdU incorporation. Cells were
visualized under a light microscope and counted to evaluate BrdU
incorporation. No BrdU staining was detected in serum-starved cells,
whereas significant amounts of staining were detected in asynchronously
growing cells. To detect the staining patterns of endogenous proteins,
appropriate mouse monoclonal and rabbit polyclonal antibodies were
used, and the same fluorescein- or Texas red-conjugated secondary
antibodies (Vector Laboratories) were employed to detect staining.
Imaging was performed using a charge-coupled device (CCD) digital
camera and deconvolution microscopy using a 100× objective lens (Scanalytics).
 |
RESULTS |
RB family members do not interact directly with HDAC.
All
members of the RB family of proteins appear to associate with class I
HDACs, including HDAC1, HDAC2, and HDAC3 (6, 21, 39, 41,
42). A direct association between HDAC1 and RB family proteins
has been suggested, based on interactions observed between purified
GST-RB and in vitro-translated HDAC1 (21, 42). To examine
the interaction between RB family proteins and HDAC1 further, we
synthesized GST-pRB(pocket) and GST-p107(pocket) proteins in bacteria
and combined each purified product with purified histidine-tagged HDAC1
isolated from SF9 insect cells infected with a baculovirus that
overexpressess His6-HDAC1. Although we believe that results similar to those described below would be obtained using the pocket of
p130, we have not been successful in obtaining suitable p130(pocket) material to conduct this type of experiment. Following incubation of
GST fusion proteins in vitro with purified HDAC1, we performed GST
pull-down experiments and detected associations by Western blotting
using anti-His antibody. Figure 1A
shows that no interaction between purified HDAC1 and
the pocket of either pRB or p107 was detectable; however, addition of
nuclear extract along with the purified proteins resulted in a
significant amount of association. These results differed from previous
assessments in that they suggested that another nuclear factor(s) could
act as a bridge in this in vitro interaction. Similar results were also
obtained using purified HDAC3 (data not shown). The association
observed previously (and demonstrated below in Fig. 6B) between pRB and in vitro-translated HDAC1 had been proposed to occur via interactions between the pocket and a degenerate IXCXE motif in HDAC1 (21, 42). Because HDAC3 lacks such a motif, HDAC3 must require other factors to associate with the pRB pocket, and the data in Fig. 1
suggest that such is also the case with HDAC1. An explanation for the
disparity between our results and those reported previously might
relate to the fact that in vitro-translated HDAC1 is defective in HDAC
activity, whereas HDAC1 purified from SF9 cells has been shown to be
enzymatically active (43). But the simplest interpretation is that both HDAC1 and HDAC3 require an additional linker protein present both in nuclear extracts and the in vitro translation mixture
used in the earlier studies. While we cannot exclude the possibility
that the pocket can bind directly to HDACs via the IXCXE motif, this
interaction may not represent the major mechanism of binding between RB
family members and HDACs.

View larger version (14K):
[in this window]
[in a new window]
|
FIG. 1.
RBP1 recruits HDAC activity to RB family members via the
R2 repression domain. (A) RB family members do not interact directly
with HDAC1. GST fusion proteins were purified from bacteria, whereas
His6-HDAC1 protein was purified from baculovirus
(baculo)-infected SF9 insect cells. Mixtures were incubated in vitro,
and binding was assessed as described below following separation
by SDS-PAGE and western blotting using anti-His antibody. Lanes 3, 4, and 6 are samples that were incubated following addition of nuclear
extracts from H1299 cells. pRB(pocket) and p107(pocket) contain only
the pocket regions of these proteins. The E1A protein used contains
only residues encoded by the first exon, including conserved region 1 and 2. (B) RBP1 constitutes half of the HDAC activity recruited by the
pocket of RB family members. d-NRS refers to extracts depleted with
NRS, and d-RBP1 denotes extracts depleted with monoclonal antibody LY11
against RBP1. Extracts were subjected to GST pull-down with or without
the indicated immunodepletion and then assessed for HDAC activity by
measuring the amount of [3H]acetate extractable by ethyl
acetate, as described in the text. (C) RBP1 is absent in extracts
depleted with monoclonal antibody LY11 against RBP1. Immunodepletion
was performed 7 to 10 times until LY11 immunoprecipitates contained
only background levels of HDAC activity, 40-µg aliquots of
immunodepleted extracts quantified by Bradford assay were combined with
various GST fusion proteins (listed at the top), as described in
Materials and Methods, and loaded into each lane. RBP1 was detected by
Western blotting using antibody LY32. HMG1 (bottom) was detected in
these extracts using a polyclonal antibody (Pharmingen). (D) pRB and
p107-associated HDAC activities are pocket dependent, and
RBP1-associated HDAC activity requires the R2 repression domain. HDAC
activity was determined as in Fig. 1B. Values in panels B and D
represent the averages of duplicate samples from three independent
experiments.
|
|
RBP1 is a factor that recruits HDAC activity to RB family
members.
We have demonstrated previously that the RB-binding
protein RBP1 may function as a bridging factor to recruit class I HDACs (39). Studies were therefore conducted to estimate the
importance of RBP1 in this association. GST-pRB fusion proteins were
shown previously to be able to recruit HDAC activity from nuclear
extracts (6, 42). We have modified this assay by
immunodepleting RBP1 from nuclear extracts using an anti-RBP1 antibody,
LY11, and then incubating such extracts with GST-pRB protein. As shown
in Fig. 1C, after seven rounds of immunodepletion with LY11 virtually no detectable RBP1 remained, as determined by Western blotting of
samples containing equal amounts of protein using another anti-RBP1 antibody, LY32. With extracts depleted using nonspecific rabbit serum
(NRS), significant amounts of RBP1 remained. Figure 1C also shows that
such immunodepletion caused little change in the levels of another
nuclear protein, HMG1. Samples were then subjected to GST pull-down
analysis and assessed directly for HDAC activity to quantify the level
of HDAC following LY11 or NRS immunodepletion. Figure 1B shows that
significant amounts of HDAC activity were associated with the pocket of
pRB and p107 after immunodepletion with NRS; however, with both pRB and
p107, HDAC activity decreased to less than half that in samples
immunodepleted with LY11 anti-RBP1. These results suggested that
RBP1-associated HDAC activity constitutes a significant proportion of
the HDAC activity associated with RB family members. It was possible
that this effect might have resulted from a depletion of the overall
pool of HDAC activity in the extract; however, no similar loss of
RB-associated HDAC activity was observed with extracts immunodepleted
using antibodies against individual class I HDACs that removed an even
greater fraction of the overall HDAC pool (Fig.
2 and data not shown). The inability to
abolish RB-associated HDAC activity completely may suggest that RBP1
may not be the only bridging factor recruiting HDACs to RB family
members. This contention is consistent with other findings that showed
that RBAP48, another RB-binding protein, and c-Ski, an LXCXE-containing
RB-binding protein, are also able to recruit HDAC1 to RB family members
(56; B. K. Kennedy, personal communication). In
addition, the failure to abolish all activity could result from the
fact that RBP1 exists in multiple isoforms (48), not all
of which may be recognized by antibody LY11.

View larger version (22K):
[in this window]
[in a new window]
|
FIG. 2.
Both pRB and RBP1 recruit class I HDAC enzymes.
Immunodepletion was performed using NRS (d-NRS), goat polyclonal
antibody against HDAC1 (d-HDAC-1) or HDAC-2 (d-HDAC2), or rabbit
polyclonal antibody against HDAC3 (d-HDAC-3). In some experiments,
these antibodies were combined and used together for immunodepletion
(d-HDAC1/2 and d-HDAC1/2/3). Following GST pull-down, HDAC activity was
measured. Values in panels A and B represent the averages of two
independent experiments. Immunodepletion was performed 7 to 10 times
until anti-HDAC immunoprecipitates associated only with background
levels of HDAC activity detected in HDAC assays. (A) pRB-associated
HDAC activities from extracts were completely abolished with extracts
depleted with HDAC1, HDAC2, and HDAC3. (B) RBP1 R2-associated HDAC
activities were completely abolished in extracts depleted for HDAC1,
HDAC2, and HDAC3. (C) Detection of the presence of different class I
HDACs in extracts depleted using different HDAC-specific antibodies.
Forty-microgram aliquots of immunodepleted extracts, as quantified by
Bradford assays, were loaded into each lane, and HDACs (or control
HMG1) were detected by Western blotting following SDS-PAGE.
|
|
R2 but not the R1 region of RBP1 recruits HDAC to the pocket of
RB.
To determine if the HDAC activity associated with RB family
members is dependent on the pocket, point mutants of pRB (C706F) and
p107 (C713F), which abolish binding of RBP1 (Fig. 4C and data not
shown), were used to detect pRB- and p107-associated HDAC activities.
Figure 1D shows that both mutants were unable to recruit significant
levels of HDAC activity, indicating that a functional pocket domain is
of great importance for the association. We have shown previously that
association of class I HDACs with RBP1 requires the R2 but not the R1
repression domain of RBP1. Consistent with our previous results, Figure
1D shows that R2 recruited high levels of HDAC activity, whereas R1
associated only with background levels. Thus, repression by R1 does not
involve HDACs that are measurable by the present assay or that are
inhibited by the HDAC inhibitor trichostatin A (TSA). All HDAC activity
associated with RB family members or the R2 repression domain of RBP1
was inhibited by TSA (data not shown), in keeping with our previous in
vivo repression studies (39). In addition, transcriptional
repression activities associated with pRB and full-length RBP1 are
known to be only partially sensitive to TSA (39, 41),
suggesting that repression by RB family members may also utilize the
HDAC-independent activity associated with the R1 repression domain of RBP1.
pRB and RBP1 recruit only class I HDAC activities.
Both RB
family members and RBP1 have been shown to associate with the class I
HDACs, HDAC1, HDAC2, and HDAC3. To determine if either can associate
with other HDACs (class II or unidentified HDACs), experiments similar
to those in Fig. 1B were performed except that antibodies against
specific class I HDAC species were used in seven rounds of
immunodepletion. Western blotting analysis shown in Fig. 2C indicated
that antibodies against either HDAC1 or HDAC2 depleted both of these
species but not much HDAC3. Similar results were obtained with a
mixture of anti-HDAC1 and anti-HDAC2 sera. This observation was
consistent with the idea that HDAC1 and HDAC2 are present together as a
complex. Anti-HDAC3 antibodies depleted not only HDAC3 but also some
amounts of HDAC1, but not HDAC2. This observation suggested that human
H1299 cells may contain complexes involving both HDAC1 and HDAC3,
unlike Jurkat and HeLa cells studied previously (24).
Addition of a mixture of antibodies against all three class I enzymes
eliminated all three but had little effect on the control nuclear
protein HMG1. Figure 2A shows that immunodepletion using any single
anti-class I HDAC antibody had only a small effect on the levels of
HDAC activity associated with pRB, whereas treatment with a mixture of
antibodies recognizing all three eliminated essentially all of the
pRB-associated HDAC activity. Almost identical results were obtained
using the R2 domain of RBP1 (Fig. 2B), indicating that both pRB and
RBP1 associate with HDAC1, HDAC2, and HDAC3 but not with other members
of the HDAC family, including class II enzymes, which we have found are abundant in the extracts used in these experiments (data not shown). Furthermore, immunoprecipitation experiments using antibodies against
HDAC4 and HDAC6 did not coimmunoprecipitate any RBP1 or RB family
members (data not shown). These data strengthen the idea that RBP1
plays an important role as a bridge between RB family members and class
I HDACs.
RBP1 recruits the mSIN3-HDAC complex.
Mammalian cells contain
two known class I HDAC complexes, the mSIN3-related and NURD HDAC
complexes (58, 59, 64, 68, 69, 70, 71). Antibodies against
mSIN3 and the SAP30 component of the mSIN3A-HDAC complex were used to
determine the association between RBP1 and this complex. Figure
3A shows that RBP1 was
coimmunoprecipitated from nuclear extracts with AK11 (anti-mSIN3A) and
AK12 (anti-mSIN3B) antibodies. Interestingly, large amounts of RBP1
were also detected using anti-SAP30 antibodies. An antibody that
recognizes the p300 histone acetyltransferase (NM11)
did not coimmunoprecipitate any RBP1 from these extracts. Figure 3B
shows that immunoprecipitation of RBP1 using antibody LY11 results in
the coprecipitation of mSIN3A, mSIN3B, low levels of pRB, and HDAC1. In
addition, Figure 3C shows that another component of all class I HDAC
complexes, RBAP46/48, is also present in immunoprecipitates prepared
using anti-RBP1 or anti-pRB antibodies but not with those against p300. HDAC activity was also measured directly using these
immunoprecipitates, and significant levels were detected using antibody
LY11 but not with anti-p300 antibody NM11 (data not shown). These
results indicated that RBP1 associates with the mSIN3-HDAC complex in
vivo.


View larger version (53K):
[in this window]
[in a new window]
|
FIG. 3.
pRB associates with mSIN3-HDAC complex via RBP1.
Coimmunoprecipitations (IP) were performed with H1299 extracts using
the indicated antibodies against components of the mSIN3-HDAC complex,
or against pRB, RBP1, or p300, under low-stringency conditions. WC
represents whole-cell extracts; 20 µg of cell protein were loaded in
each lane, and apart from panel E, proteins were identified by Western
blotting using the antibodies indicated. (A) RBP1 coimmunoprecipitates
with components of the mSIN3-HDAC complex. (B) Immunoprecipitation of
RBP1 or pRB coprecipitates components of the mSIN3-HDAC complex.
Antibody C-15 recognizes the carboxy terminus of pRB, whereas C36,
XZ91, and IF8 recognize regions of the pRB pocket. IgGH,
immunoglobulin G heavy chain. (C) Immunoprecipitation of RBP1
coprecipitates RBAP46/48. Polyclonal antibody C-15 or monoclonal
antibody LY11 was used to immunoprecipitate RBP1. Anti-p300 antibody
NM11 was used as a control. (D) Immunoaffinity-purified SAP30
complexes. HeLa cell extracts were immunoaffinity purified using
anti-SAP30 antibody and separated by SDS-PAGE, and the purified
proteins were visualized by silver staining. The input for
immunoaffinity purifications was the 0.35 M KCl eluate of DE-52 columns
prepared from the 0.5 M KCl phosphocellulose fraction of HeLa cell
nuclear extracts. Proteins were washed with a buffer containing 0.5 M
KCl and 0.05% NP-40 and eluted with Tris-glycine (pH 2.6). (E) Western
blotting of input (in), flowthrough (ft), and bound (b) fractions of
HeLa cell nuclear extracts subjected to immunoaffinity purification
using anti-SAP30 and anti-HDAC1 antibodies. Anti-FLAG immunoaffinity
columns were used as a negative control. (F) Immunoprecipitation of
RBP1 in RB / H596 lung cancer cells. Anti-pRB antibody
C-15, anti-p107 antibody SD9, and anti-p130 antibody C-20 were used to
immunoprecipitate RB family members in asynchronously growing H596 cell
extracts. Coimmunoprecipitation of RBP1 was detected by Western
blotting analysis using LY32 anti-RBP1 antibody.
|
|
It is interesting that the only anti-pRB antibody capable of
coimmunoprecipitating RBP1, RBAP46/48, HDAC1, mSIN3A, and
mSIN3B
was C-15, despite the fact that all RB antibodies are capable
of
immunoprecipitating large amounts of the various forms of pRB
(Fig.
3A
and B). More interestingly, only antibody C-15 was able
to
coimmunoprecipitate HDAC1, suggesting that the majority of
HDAC1
associated with pRB may be via RBP1. Antibody C-15 targets
the carboxy
terminus of pRB and thus may not disrupt the pocket
region, which is
crucial for recruitment of HDAC activity both
in vitro and in vivo and
for binding RBP1 (
6,
39,
41,
42).
The other anti-pRB
antibodies tested were either raised against
regions of the pocket or
capable of disrupting the integrity of
the pocket upon binding. These
antibodies might therefore either
disrupt RBP1-HDAC binding to the
pocket or fail to recognize pRB
molecules in which the pocket is
occupied by the RBP1 complexes.
To demonstrate that coprecipitation of
RBP1 by antibody C-15 results
from its specificity for pRB and not from
any cross-reactivity
with RBP1, immunoprecipitation experiments similar
to those shown
in Fig.
3A and B were performed with H596 lung cancer
cells lacking
pRB. Figure
3F demonstrates that no RBP1 was present in
immunoprecipitates
from these cells prepared using antibody C-15,
whereas with anti-p107
antibody SD9, RBP1 was coprecipitated. Figure
3F
also shows that
anti-p130 antibody C-20 failed to coprecipitate RBP1,
presumably
because p130 levels are extremely low in asynchronously
growing
cells (reference
10 and data not shown). Thus,
these results
further support the idea that the mSIN3-HDAC complex is
recruited
to pRB via a pocket-dependent association with
RBP1.
Further evidence for the role of RBP1 in recruiting the SIN3-HDAC
complex was obtained in an analysis of material that had
been
immunoaffinity purified from HeLa cells using antibodies
against SAP30,
a component of this complex. Figure
3D shows an
SDS-PAGE profile and
silver staining of members of the complex.
A separate study using ion
trap mass spectroscopy confirmed the
presence of a series of HDACs,
mSIN3A, RBAP48/46, and a 180-kDa
species found to represent RBP1
(
68,
71). Figure
3E shows
similar affinity purifications
of HeLa cell extracts using anti-FLAG
(control), anti-SAP30, and
anti-HDAC1 antibodies, which were analyzed
following SDS-PAGE by
Western blotting using anti-RBP1, anti-HDAC1,
and anti-SAP30
antibodies. None of these species were retained
(Fig.
3E, lanes b)
using anti-FLAG antibodies, but all were bound
in the anti-SAP30 and
anti-HDAC1 samples. These data confirmed
RBP1 as a stable member of
this complex. The 180-kDa RBP1 species
was not detected in a parallel
study using anti-Mi-2 antibodies,
thus confirming that RBP1 is not
present in the NURD-HDAC complex
(references
68 and
71 and
data not shown). Interestingly,
RB family members and E2F were not
detected in this stable complex
(data not shown). The absence of these
species may be explained
in three ways. First, the complex was isolated
from HeLa cells,
which express human papillomavirus (HPV) E7 protein.
HPV E7 has
been shown to prevent the pocket of pRB from recruiting HDAC
activity.
These observations were consistent with our previous results
showing
that RBP1 and HDACs fail to associate at high levels with RB
family
members in 293 and 293T cells, which express adenovirus E1A
protein
and simian virus 40 large T antigen (
39). Second,
both class
I HDACs and RBP1 associate only with the hypophosphorylated
form
of pRB, and pRB is known to be highly phosphorylated in HeLa
cells.
Finally, pRB-RBP1-mSIN3-HDAC complex formation appears to be
cell
cycle dependent (
10) and may represent only a small
fraction
of the pool of HDAC complexes in this rapidly growing
population
of cells. Nevertheless, these results suggested that RBP1
recruits
the mSIN3-HDAC complex to RB family members in a pocket
-dependent
manner.
R2 repression domain recruits mSIN3-HDAC complex.
We generated
a series of RBP1 deletion mutants and expressed them as GST fusion
proteins (Fig. 4B). Using these mutant
GST-RBP1 proteins as well as GST fusion products containing either
SAP30 or adenovirus E1A protein, the binding of components of the
mSIN3-HDAC complex was examined further. Figure 4A shows that the only
RBP1 product that associated with mSIN3B and HDAC1 was GST-R2, thus confirming that the R2 region is uniquely responsible for binding of
the mSIN3-HDAC complex to RBP1. This finding was further strengthened by results shown in Fig. 4C, which indicated that GST-R2 but not GST-R1
was able to bind to mSIN3B, RBAP46/48, HDAC1/2, and Sap30 present in
nuclear extracts. In addition, Fig. 4C shows that both GST-pRB and
GST-p107 recognized these same components of the mSIN3-HDAC complex.
Failure of such binding by the pRB pocket mutant C706F confirmed the
requirement of the pocket for this association with RBP1 and the
mSIN3-HDAC complex. These experiments demonstrated that the R2
repression domain of RBP1 is responsible for recruiting the entire
mSIN3-HDAC complex.

View larger version (23K):
[in this window]
[in a new window]
|
FIG. 4.
RBP1 recruits the mSIN3-HDAC complex via the R2
repression domain. GST pull-down experiments were performed using
extracts from H1299 cells and the indicated GST fusion proteins bound
to glutathione-Sepharose beads. (A) Only the R2 repression domain of
RBP1 binds mSIN3B and HDAC1 in vitro. GST pull-downs assays were
performed, and mSIN3B and HDAC1 were detected by Western blotting using
appropriate antibodies. WC represents whole-cell extracts; 20 µg of
GST fusion protein was used in each pull-down experiment presented in
each lane. (B) Schematic diagram of RBP1 truncation mutants of GST-RBP1
fusion proteins. (C) The R2 repression domain, pRB, and p107 bind other
components of mSIN3-HDAC complex, including mSIN3A, mSIN3B, HDAC1,
HDAC2, RBAP46/48, and SAP30. GST pull-down experiments were performed,
and binding of the indicated proteins was assessed by Western blotting
using appropriate antibodies. Mutant C706F is defective in the pRB
pocket.
|
|
RBP1 binds to HDAC via SAP30.
To identify the protein that is
directly responsible for binding of the mSIN3-HDAC complex to the R2
domain of RBP1, purified GST-R2 protein was incubated in vitro with
various components of the complex, and binding was assessed in GST
pull-down experiments as in Fig. 4. Figure
5A shows results obtained by Western
blotting using anti-His antibody and indicated that His6
HDAC1, which had been synthesized in and purified from SF9 insect
cells, failed to associate with RBP1-R1 or with a deletion mutant of
RBP1 (dl 1208C) that lacks the carboxy-terminal R2 domain, even in the presence of nuclear extracts. Binding was not apparent with the R2
domain either, unless nuclear extract was added. These results suggested that HDAC1 does not interact directly with R2 but rather does
so via another factor found in nuclear extracts. Figure 5B shows
results of similar experiments carried out with other components of the
mSIN3-HDAC complex which had been translated in vitro using appropriate
cDNAs in rabbit reticulocyte lysates in the presence of
[35S]methionine and detected by autoradiography following
SDS-PAGE. Interestingly, only in vitro-translated SAP30 was able to
associate with the R2 domain of RBP1. Some level of association of
HDAC1 with GST-pRB in a pocket -dependent manner was also observed, as
also seen by others. It should be noted that SAP30 did not interact
with GST-dl747C, a truncation mutant of RBP1 that contains R1 but not
R2, nor with GST-pRB, suggesting that utilizing R2, RBP1 truly
functions as a bridge to recruit mSIN3-HDAC complex to the pocket of
pRB. To strengthen this contention further, various GST fusion proteins
and His-SAP30 were synthesized in and purified from bacteria and
incubated together in vitro. GST pull-down assays were performed, and
binding of His-SAP30 was assessed by Western blotting using anti-His
antibody. GST-HDAC1 was demonstrated previously by others to bind
directly with SAP30 (71) and was used as a positive
control in this experiment. Figure 5C shows that GST-R2 interacted
directly with purified SAP30 protein as did GST-HDAC3; however, GST-R1,
GST-pRB, and GST alone did not. These results indicated that the
association of the mSIN3-HDAC complex with the R2 domain of RBP1 likely
occurs via SAP30. In addition, the association seen between HDAC3 and
SAP30 in vitro may suggest that there exists a pool of mSIN3-SAP30-HDAC
complex that contains HDAC3 as a subunit. This observation further
supported results in Fig. 2C, which suggested that there may be a pool
of complex containing both HDAC1 and HDAC3 as subunits that constitute
part of the HDAC activity recruited by pRB and RBP1.

View larger version (15K):
[in this window]
[in a new window]
|
FIG. 5.
The R2 repression domain associates with mSIN3-HDAC
complex via a direct interaction with SAP30. (A) R2 repression domain
does not interact directly with HDAC1. Lane 1 is loaded with 0.2 µg
of His6-HDAC1 protein. Lanes 3, 5, and 6 contain samples in
which purified proteins were also incubated in the presence of H1299
nuclear extracts. Binding of HDAC1 was assessed in GST pull-down
experiments followed by Western blotting using anti-His antibody. (B)
[35S]methionine-labeled in vitro-translated SAP30
associates with the R2 repression domain specifically. Labeled in
vitro-translated SAP30 (lane Input, containing 1/10 of the total) was
incubated with the indicated GST fusion proteins. Binding was assessed
by autogradiography. (C) Purified SAP30 binds directly with purified
RBP1 R2 domain, HDAC1, and HDAC3. Binding was assessed by Western
blotting using anti-His antibody.
|
|
RBP1 and RB family members require SAP30 to recruit HDAC
activity.
To determine if SAP30 is essential for pRB and p107 to
recruit HDAC activity, an immunodepletion study similar to that
described in Fig. 1B was carried out using a polyclonal antibody that
recognizes SAP30. Figure 6B shows that
anti-SAP30 antibody removed SAP30 from the extracts while not affecting
levels of the control nuclear protein HMG1. As shown in Fig. 6A,
immunodepletion of SAP30 completely abolished the association of HDAC
activity with the R2 domain of RBP1. Consistent with our earlier
results with RBP1 immunodepletion, more than half of the HDAC activity
recruited by the pockets of both p107 and pRB was abolished in
SAP30-depleted extracts. This experiment therefore demonstrated that
the SAP30-containing mSIN3-HDAC complex recruited by the R2 region of
RBP1 is responsible for at least 50% of the HDAC activity present at
the pocket of RB family members.


View larger version (41K):
[in this window]
[in a new window]
|
FIG. 6.
SAP30 is required for the RBP1 R2 repression domain to
recruit HDAC activity. (A) SAP30 constitutes at least half of the HDAC
activity recruited by the pocket of RB family members. Immunodepletion
was performed as in Fig. 1 and 2, using anti-SAP30 antibodies (d-SAP30)
or control NRS (d-NRS). HDAC activity was measured as in Fig. 1 and 2.
(B) SAP30 is absent in extracts depleted using antibodies against
SAP30. Immunodepletion was performed 7 to 10 times until anti-SAP30
immunoprecipitates associated with background levels of HDAC activity;
40 µg of immunodepleted extract quantified by Bradford assays was
loaded into each lane. SAP30 was detected by the same polyclonal
antibody used for immunodepletion by Western blotting following
SDS-PAGE. HMG1 was detected using a polyclonal antibody (Pharmingen).
|
|
pRB colocalizes with RBP1 and mSIN3-HDAC complex in quiescent
cells.
The biochemical evidence presented in this study suggested
that pRB-E2F complexes can recruit mSIN3-HDAC complex via RBP1. If such
complexes exist in vivo, individual components should colocalize in
cells within the nucleus. To determine the relative cellular
localization of RBP1 and various binding partners, quiescent primary
human diploid fibroblasts were studied because we previously detected
pRB-RBP1-E2F complexes in growth-arrested cells (40). WI38
human diploid fibroblasts were serum starved for 3 days, and BrdU
incorporation studies were performed to determine if the cells had
exited the cell cycle. Immunofluoresence studies were also performed
using various monoclonal and polyclonal antibodies against BrdU, RBP1,
pRB, E2F4, HDAC1, HDAC2, HDAC3, HDAC4, HDAC6, mSIN3A, and SAP30.
High-resolution deconvolution microscopy utilizing a CCD digital camera
was used to image these stained cells. Figure 7A shows that using two
different monoclonal antibodies (LY32 and LY48) and one
polyclonal (amino-terminal) antibody against RBP1, similar staining
patterns showing very discrete regions within nuclei were observed in
these cells. When the green and red channels were merged, the yellow
spots represented the highest concentrations of RBP1, and thus the most
representative of the true location of RBP1. BrdU staining was not
detected in these cells, indicating that they were in full growth
arrest (data not shown). Figure 7B shows that pRB,
p130, and E2F4 also colocalized in these RBP1-containing discrete
nuclear regions. Similar studies were not carried out with p107, as we
and others have found p107 levels to be undetectable in quiescent cells
(10, 40). As shown in separate colocalization studies
(35; B. K. Kennedy, D. A. Barbie, A. Lai, M. Classon, N. Dyson, P. E. Branton, and E. Harlow, unpublished
results). these regions appear to occupy perinucleolar sites and do not
appear to be those containing promyelocytic leukemia (PML) bodies.
Rather, these same regions were found to contain the initial origins of
DNA replication following serum stimulation (35; Kennedy
et al., unpublished) (see Discussion). As biochemical studies implied a
specific association of RBP1 with class I HDACs, similar colocalization
studies were performed comparing RBP1 to HDAC1 to -3. Figure 7C shows
that HDAC2 also largely colocalizes to these discrete RBP1-containing
regions, as did HDAC1 and HDAC3 (data not shown). Interestingly, Figure 7C also shows that class II HDAC4 and HDAC6 exhibit quite different staining patterns and did not colocalize with RBP1 at significant levels, as was consistent with our immunodepletion studies. Finally, and consistent with the previous biochemical data, Figure 7D shows that
a significant number of stained foci of both mSIN3A and SAP30 also
colocalized with RBP1. These results confirmed that RBP1 exists in
resting cells in association with pRB, p130, and components of the
mSIN3-HDAC complex.




View larger version (72K):
[in this window]
[in a new window]
|
FIG. 7.
RBP1 colocalizes with pRB-E2F and components of the
mSIN3-HDAC complex in quiescent WI38 human diploid fibroblasts. All
photographs were taken using a CCD camera attached to a deconvolution
microscope with a 100× objective lens. (Left panels) Mouse monoclonal
antibody was detected by Texas red-conjugated secondary antibody
against mouse immunoglobulin G, which appears fluorescent in the red
channel. (Middle panels) Rabbit polyclonal antibody was detected by
fluorescein-conjugated secondary antibody against rabbit immunoglobulin
G, which appears fluorescent in the green channel.
4',6-Diamidino-2-phenylindole staining was used to stain the nucleus
and appears fluorescent at the blue channel. (Right panels) Merged
pictures represent superimposed blue, red, and green channels, and
yellow fluorescence indicates positions of colocalization. (A)
Localization pattern of RBP1 within the nucleus, using multiple
antibodies against RBP1. (B) RBP1 colocalizes with pRB, p130, and E2F4
in discrete regions of the nucleus. (C) RBP1 colocalizes with class I
HDACs but not class II HDACs within the nucleus. (D) RBP1 colocalizes
with both mSIN3A and SAP30 within the nucleus.
|
|
 |
DISCUSSION |
Active repression function of pRB requires RBP1.
This study
demonstrates the role of RBP1 as a bridging factor that recruits
mSIN3-HDAC complexes to the pocket of RB family members. One of the
important biological functions of the RB family is to regulate
expression of genes required for cell cycle progression and DNA
synthesis. RB family members utilize the pocket domain to recruit HDAC
activities to repress transcription of these genes in early
G1 or when cells exit the cell cycle. We have provided evidence here that RB family members are able to recruit the mSIN3-HDAC complex via a pocket -dependent association with RBP1 to actively repress transcription. Although not all of the HDAC activity associated with pRB can be accounted for by the recruitment of RBP1 as a corepressor, this mechanism may account for over half of such activity.
The remaining activity may associate through interactions with other
bridging factors, possibly including RBAP46/48 and c-Ski, or some
other, unidentified pocket-binding protein that associate with HDAC
complexes. Nonetheless, RBP1 is the first molecule described that
appears to contribute two separate classes of transcriptional
repression activities important for transcriptional repression by RB
family members, both by recruiting the mSIN3-HDAC complex via R2 and
via an as yet unidentified repression mechanism utilizing the R1 domain
(Fig. 8). These dual repression
activities of RBP1 may account for the ability of pRB to repress
transcription in a variety of promoters, including those that have been
reported to be insensitive or only partially sensitive to the HDAC
inhibitor TSA.

View larger version (26K):
[in this window]
[in a new window]
|
FIG. 8.
Model of transcriptional repression by pRB-E2F complexes
during quiescence and the early G1 phase of the cell cycle
involving recruitment of the mSIN3-HDAC complex through the
pocket-dependent association of RBP1.
|
|
The structure of the pRB pocket in association with a peptide
containing the HPV E7 LXCXE sequence has allowed three independent
groups to introduce point mutations that appear to abolish the
ability
of the pRB pocket to interact with the LXCXE motif without
affecting
binding to E2F (
9,
11,
15). Interestingly, two
groups
observed that LXCXE-mediated binding is important for the
ability of
pRB to induce growth arrest (
9,
11), whereas the
other
group found that such did not appear to be the case (
15).
This difference could stem from the different assay systems used
or
perhaps from subtle effects of the different pocket mutations
used. The
same two groups (
9,
11) also showed that HDAC1
interactions with the pocket were abolished with their mutants.
Thus,
our result that RBP1 bridges the interaction between HDAC1/2
and pRB
supports this finding, as RBP1 utilizes an LXCXE motif
to associate
with the pocket. Evidence suggesting that the HDAC3-pRB
interaction
remains intact with the pocket mutants has also been
obtained
(
11). This effect is somewhat unexpected, as we found
that
HDAC3 also interacts with RBP1, and we have proposed that
HDAC3 is also
recruited in a pocket -dependent manner despite
the absence of an LXCXE
motif (
39). HDAC3 has recently been
shown to be part of
the NCoR complex, which is distinct from the
SIN3-SAP30-HDAC1/2
complex. It is possible that HDAC3 associated
with this complex could
be recruited to pRB via contacts other
than the LXCXE-interacting
regions. Thus, we continue to believe
that HDAC3 found in the SIN3
complex associates with the pocket
via RBP1 contact, but that HDAC3 may
able to associate with RB
via different vehicles. In general, our
results support results
from the two groups that present evidence that
LXCXE pocket-binding
proteins are important for the ability for RB to
induce growth
arrest and active
repression.
pRB and p130 recruit the RBP1-mSIN3-HDAC complex in quiescent
cells.
In previous studies we had detected stable p130-E2F-RBP1
and pRB-E2F-RBP1 complexes capable of binding consensus E2F-specific DNA sequences in quiescent cell extracts (40). Consistent
with these previous findings, we have now found that in quiescent
cells, RBP1 and mSIN3-HDAC complexes colocalize to regions of the
nucleus containing RB family members and E2F4. Other studies
(35; Kennedy et al., unpublished) indicated that pRB
redistributes to other regions of the nucleus later in the cell cycle
and that it no longer colocalizes with either class I HDAC or RBP1 in
cells in late S phase. Such observations suggest that induction of gene expression required for S-phase progression may involve a mechanism that relocates the RBP1-mSIN3-HDAC complexes. One interesting finding
was that class II HDACs had very different staining patterns and did
not colocalize with RBP1 or RB family members. This observation distinguishes the pRB- or RBP1-mediated mechanism of transcriptional repression from that of nuclear hormone receptors, which appear to
utilize both classes of HDACs (29, 34).
It was also observed that SAP30 does not colocalize perfectly with
RBP1, despite the fact that RBP1 recruitment of HDAC activity
absolutely requires the presence of SAP30. These results suggested
that
not all SAP30-containing complexes contain RBP1; consistent
with this
notion, SAP30 was also found in HDAC complexes involved
in the action
of nuclear hormone receptors through association
with NCoR/SMRT and in
other complexes (
38). SAP30-containing
complexes may be
involved in multiple cellular processes, whereas
RBP1-containing
SAP30-HDAC complexes may specifically function
with RB family
members.
Model of cell cycle exit and progression control by RB family
members.
Zhang et al. had previously demonstrated the importance
of the transcriptional repression function of pRB in cells induced into
growth arrest by p16, contact inhibition, or transforming growth factor
(67). Their work suggested that blocking of E2F
transactivation by pRB is not sufficient to induce such growth arrest.
Here we have presented evidence that a complex containing HDAC activity
associates with RB family members in quiescent cells. This complex
appeared to be largely the previously identified mSIN3-SAP30-containing
HDAC complex that also contains a newly identified subunit, RBP1, which
appears to bridge it to RB family members. Figure 8 illustrates this
new model in which RB family members induce growth arrest by recruiting
the mSIN3-HDAC complex to the pocket via a direct association with the
RBP1 subunit of the complex. Biochemical evidence presented in this
study suggested that RBP1 contacts SAP30 directly via the R2 repression
domain, whereas SAP30 interacts directly with HDAC1 and HDAC2 within
the complex. RBAP46 and RBAP48, which are also found in the complex, may also have contacts with regions of pRB; however, experiments in
Fig. 4 and 5B and those by others (Kennedy, personal communication) failed to detect any interaction in vitro between pRB and RBAP48. mSIN3A and mSIN3B do not interact directly with RBP1 and may be associated with RBP1 through direct interactions with SAP30 and SAP18.
The precise functions of individual components of this complex in
transcriptional repression function are still unclear, but RBP1 may
serve to target this complex to pRB and also provide a second
HDAC-independent repression activity that may be of critical importance
in some cases. Further studies to address this issue are under way.
An additional role for the E2F-pRB-RBP1-SAP30-mSIN3-HDAC complexes
might be proposed based on recent studies on the localization
of such
complexes in normal human cells (
35; Kennedy et al.,
unpublished). These studies indicated that the discrete regions
occupied by such complexes are those that first incorporate BrdU
following serum stimulation of growth-arrested cells and thus
represent
the initial origins of DNA replication. It is possible
therefore that
the HDAC complexes targeted to these regions by
RBP1 function in cell
cycle exit not only by repressing transcription
but also by remodeling
chromatin at these critical sites, thus
blocking the origins and
possibly serving as targets for initiation
of DNA synthesis. Again,
further studies will be required to test
this
model.
 |
ACKNOWLEDGMENTS |
We thank Bill Kaelin and Jim DeCaprio for providing monoclonal
antibodies against RBP1. We also thank Eva Lee, Betty Moran, and Bob
Eisenman for providing additional reagents. Wei-Ming Yang and Ed Seto
provided class I HDAC-related reagents; those for class II HDAC were
from Xiang Jiao Yang and Nick Bertos. Deconvolution microscopy was
performed at the Whitehead Institute Microscopy Facility.
This work was supported through grants to P.E.B. from the National
Cancer Institute of Canada and the Canadian Institutes for Health
Research and to D.R. from NIH (GM485180) and the HHMI. A. L. is
the recipient of Terry Fox Biomedical Studentship supported by National
Cancer Institute of Canada. M.-C.T is supported by a scholarship from
the Fonds pour la Formation de Chercheurs et l' Aide à la
Recherche (FRSQ-FCAR-Santé). B.K.K. is supported by a Leukemia
Society of America Fellowship, D.A.B. is supported by a Karen Grunebaum
Cancer Research Fellowship, and Y.Z. is supported by an NIH Fellowship.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Biochemistry, McGill University, McIntyre Medical Building, 3655 Drummond St., Montreal, Quebec, Canada H3G 1Y6. Phone: (514) 398-7268. Fax: (514) 398-7384. E-mail: branton{at}med.mcgill.ca.
 |
REFERENCES |
| 1.
|
Adnane, J.,
Z. Shao, and P. D. Robbins.
1995.
The retinoblastoma susceptibility gene product represses transcription when directly bound to the promoter.
J. Biol. Chem.
270:8837-8843[Abstract/Free Full Text].
|
| 2.
|
Ayer, D. E.
1999.
Histone deacetylases: transcriptional repression with SINers and NuRDs.
Trends Cell Biol.
9:193-198[CrossRef][Medline].
|
| 3.
|
Bernards, R.
1997.
E2F: a nodal point in cell cycle regulation.
Biochim. Biophys. Acta
1333:M33-M40[Medline].
|
| 4.
|
Björklund, S.,
G. Almouzni,
I. Davidson,
K. P. Nightingale, and K. Weiss.
1999.
Global transcription regulators of eukaryotes.
Cell
96:759-767[CrossRef][Medline].
|
| 5.
|
Brehm, A., and T. Kouzarides.
1999.
Retinoblastoma protein meets chromatin.
Trends Biochem. Sci.
24:142-145[CrossRef][Medline].
|
| 6.
|
Brehm, A.,
E. A. Miska,
D. J. McCance,
J. L. Reid,
A. J. Bannister, and T. Kouzarides.
1998.
Retinoblastoma protein recruits histone deacetylase to repress transcription.
Nature
391:597-601[CrossRef][Medline].
|
| 7.
|
Bremner, R.,
B. L. Cohen,
M. Sopta,
P. A. Hamel,
C. J. Ingles,
B. L. Gallie, and R. A. Phillips.
1995.
Direct transcriptional repression by pRB and its reversal by specific cyclins.
Mol. Cell. Biol.
15:3256-3265[Abstract].
|
| 8.
|
Carmen, A. A.,
S. E. Rundlett, and M. Grunstein.
1996.
HDA1 and HDA3 are components of a yeast histone deacetylase (HDA) complex.
J. Biol. Chem.
271:15837-15844[Abstract/Free Full Text].
|
| 9.
|
Chen, T. T., and J. Y. Wang.
2000.
Establishment of irreversible growth arrest in myogenic differentiation requires the RB LXCXE-binding function.
Mol. Cell. Biol.
20:5571-5580[Abstract/Free Full Text].
|
| 10.
|
Corbeil, H. B., and P. E. Branton.
1997.
Characterization of an E2F-p130 complex formed during growth arrest.
Oncogene
15:657-668[CrossRef][Medline].
|
| 11.
|
Dahiya, A.,
M. R. Gavin,
R. X. Luo, and D. C. Dean.
2000.
Role of the LXCXE binding site in Rb function.
Mol. Cell. Biol.
20:6799-6850[Abstract/Free Full Text].
|
| 12.
|
Dallas, P. B.,
P. Yaciuk, and E. Moran.
1997.
Characterization of monoclonal antibodies raised against p300: both p300 and CBP are present in intracellular TBP complexes.
J. Virol.
71:1726-1731[Abstract].
|
| 13.
|
Dalton, S.
1992.
Cell cycle regulation of the human cdc2 gene.
EMBO J.
11:1797-1804[Medline].
|
| 14.
|
Dangond, F.,
D. A. Hafler,
J. K. Tong,
J. Randall,
R. Kojima,
N. Utku, and S. R. Gullans.
1998.
Differential display cloning of a novel human histone deacetylase (HDAC3) cDNA from PHA-activated immune cells.
Biochem. Biophys. Res. Commun.
242:648-652[CrossRef][Medline].
|
| 15.
|
Dick, F. A.,
E. Sailhamer, and N. J. Dyson.
2000.
Mutagenesis of the pRB pocket reveals that cell cycle arrest functions are separable from binding to viral oncoproteins.
Mol. Cell. Biol.
20:3715-3727[Abstract/Free Full Text].
|
| 16.
|
Dunaief, J. L.,
B. E. Strober,
S. Guha,
P. A. Khavari,
K. Alin,
J. Luban,
M. Begemann,
G. R. Crabtree, and S. P. Goff.
1994.
The retinoblastoma protein and BRG1 form a complex and cooperate to induce cell cycle arrest.
Cell
79:119-130[CrossRef][Medline].
|
| 17.
|
Dyson, N.
1998.
The regulation of E2F by pRB-family proteins.
Genes Dev.
12:2245-2262[Free Full Text].
|
| 18.
|
Emiliani, S.,
W. Fischle,
C. Van Lint,
Y. Al-Abed, and E. Verdin.
1998.
Characterization of a human RPD3 ortholog, HDAC3.
Proc. Natl. Acad. Sci. USA
95:2795-2800[Abstract/Free Full Text].
|
| 19.
|
Ewen, E. M.,
Y. G. Xing,
J. B. Lawrence, and D. M. Livingston.
1991.
Molecular cloning, chromosomal mapping, and expression of the cDNA for p107, a retinoblastoma gene product-related protein.
Cell
66:1155-1164[CrossRef][Medline].
|
| 20.
|
Fattaey, A. R.,
E. Harlow, and K. Helin.
1993.
Independent regions of adenovirus E1A are required for binding to and dissociation of E2F-protein complexes.
Mol. Cell. Biol.
13:7802-7812[Abstract/Free Full Text].
|
| 21.
|
Ferreira, R.,
L. Magnaghi-Jaulin,
P. Robin,
A. Harel-Bellan, and D. Trouche.
1998.
The three members of the pocket proteins family share the ability to repress E2F activity through recruitment of a histone deacetylase.
Proc. Natl. Acad. Sci. USA
95:10493-10498[Abstract/Free Full Text].
|
| 22.
|
Flemington, E. K.,
S. H. Speck, and W. G. J. Kaelin.
1993.
E2F-1 mediated transactivation is inhibited by complex formation with the retinoblastoma susceptibility gene product.
Proc. Natl. Acad. Sci. USA
90:6914-6918[Abstract/Free Full Text].
|
| 23.
|
Hamel, P. A.,
R. M. Gill,
R. A. Phillips, and B. L. Gallie.
1992.
Transcriptional repression of the E2-containing promoters EIIaE, c-myc, and RB1 by the product of the RB1 gene.
Mol. Cell. Biol.
12:3431-3438[Abstract/Free Full Text].
|
| 24.
|
Hassig, C. A.,
J. K. Tong,
T. C. Fleischer,
T. Owa,
P. G. Grable,
D. E. Ayer, and S. L. Schreiber.
1998.
A role for histone deacetylase activity in HDAC1-mediated transcriptional repression.
Proc. Natl. Acad. Sci. USA
95:3519-3524[Abstract/Free Full Text].
|
| 25.
|
He, S.,
B. L. Cook,
B. E. Deverman,
U. Weihe,
F. Zhang,
V. Prachand,
J. Zheng, and S. J. Weintraub.
2000.
E2F is required to prevent inappropriate S-phase entry of mammalian cells.
Mol. Cell. Biol.
20:363-371[Abstract/Free Full Text].
|
| 26.
|
Helin, K.
1998.
Regulation of cell proliferation by the E2F transcription factors.
Curr. Opin. Genet. Dev.
8:28-35[CrossRef][Medline].
|
| 27.
|
Helin, K.,
E. Harlow, and A. Fattaey.
1993.
Inhibition of E2F-1 transactivation by direct binding of the retinoblastoma protein.
Mol. Cell. Biol.
13:6501-6508[Abstract/Free Full Text].
|
| 28.
|
Hiebert, S. W.
1993.
Regions of the retinoblastoma gene product required for its interaction with the E2F transcription factor are necessary for E2 promoter repression and pRb-mediated growth suppression.
Mol. Cell. Biol.
13:3384-3391[Abstract/Free Full Text].
|
| 29.
|
Huang, E. Y.,
J. Zhang,
E. A. Miska,
M. G. Guenther,
T. Kouzarides, and M. A. Lazar.
2000.
Nuclear receptor corepressors partner with class II histone deacetylases in a Sin3-independent repression pathway.
Genes Dev.
14:45-54[Abstract/Free Full Text].
|
| 30.
|
Ikeda, M. A., and J. R. Nevins.
1993.
Identification of distinct roles for separate E1A domains in disruption of E2F complexes.
Mol. Cell. Biol.
13:7029-7035[Abstract/Free Full Text].
|
| 31.
|
Johnson, D. G.,
K. Ohtani, and J. R. Nevins.
1994.
Autoregulatory control of E2F1 expression in response to positive and negative regulators of cell cycle progression.
Genes Dev.
8:1759-1771[Abstract/Free Full Text].
|
| 32.
|
Kadosh, D., and K. Struhl.
1997.
Repression by Ume6 involves recruitment of a complex containing Sin3 corepressor and Rpd3 histone deacetylase to target promoters.
Cell
89:365-371[CrossRef][Medline].
|
| 33.
|
Kaelin, W. J.,
D. C. Pallas,
J. A. DeCaprio,
F. J. Kaye, and D. M. Livingston.
1991.
Identification of cellular proteins that can interact specifically with the T/E1A-binding region of the retinoblastoma gene product.
Cell
64:521-532[CrossRef][Medline].
|
| 34.
|
Kao, H.-Y.,
M. Downes,
P. Ordentlich, and R. M. Evans.
2000.
Isolation of a novel histone deacetylase reveals that class I and class II deacetylases promote SMRT-mediated repression.
Genes Dev.
14:55-66[Abstract/Free Full Text].
|
| 35.
|
Kennedy, B. K.,
D. A. Barbie,
N. Dyson, and E. Harlow.
2000.
Nuclear organization of DNA replication in primary mammalian cells.
Genes Dev.
14:2855-2868[Abstract/Free Full Text].
|
| 36.
|
Kingston, R. E., and G. J. Narlikar.
1999.
ATP-dependent remodeling and acetylation as regulators of chromatin fluidity.
Genes Dev.
13:2339-2352[Free Full Text].
|
| 37.
|
Kouzarides, T.
1999.
Histone acetylases and deacetylases in cell proliferation.
Curr. Opin. Genet. Dev.
9:40-48[CrossRef][Medline].
|
| 38.
|
Laherty, C. D.,
A. N. Billin,
R. M. Lavinsky,
G. S. Yochum,
A. C. Bush,
J. M. Sun,
T. M. Mullen,
J. R. Davie,
D. W. Rose,
C. K. Glass,
M. G. Rosenfield,
D. E. Ayer, and R. N. Eisenman.
1998.
SAP30, a component of the mSin3 corepressor complex involved in N-CoR-mediated repression by specific transcription factors.
Mol. Cell
2:33-42[CrossRef][Medline].
|
| 39.
|
Lai, A.,
J. M. Lee,
W. M. Yang,
J. A. DeCaprio,
W. G. Kaelin, Jr.,
E. Seto, and P. E. Branton.
1999.
RBP1 recruits both histone deacetylase-dependent and -independent repression activities to retinoblastoma family proteins.
Mol. Cell. Biol.
19:6632-6641[Abstract/Free Full Text].
|
| 40.
|
Lai, A.,
R. C. Marcellus,
H. B. Corbeil, and P. E. Branton.
1999.
RBP1 induces growth arrest by repression of E2F-dependent transcription.
Oncogene
18:2091-2100[CrossRef][Medline].
|
| 41.
|
Luo, R. X.,
A. A. Postigo, and D. C. Dean.
1998.
Rb interacts with histone deacetylase to repress transcription.
Cell
92:463-473[CrossRef][Medline].
|
| 42.
|
Magnaghi-Jaulin, L.,
R. Groisman,
I. Naguibneva,
P. Robin,
S. Lorain,
J. P. Le Villain,
F. Troalen,
D. Trouche, and A. Harel-Bellan.
1998.
Retinoblastoma protein represses transcription by recruiting a histone deacetylase.
Nature
391:601-605[CrossRef][Medline].
|
| 43.
|
Martínez-Balbás, M. A.,
U.-M. Bauer,
J. S. Nielsen,
A. Brehm, and K. Kouzarides.
2000.
Regulation of E2F1 activity by acetylation.
EMBO J.
19:662-671[CrossRef][Medline].
|
| 44.
|
Miska, E. A.,
C. Karlsson,
E. Langley,
S. J. Nielsen,
J. Pines, and T. Kouzarides.
1999.
HDAC4 deacetylase associates with and represses the MEF2 transcription factor.
EMBO J.
18:5099-5107[CrossRef][Medline].
|
| 45.
|
Nevins, J. R.
1998.
Toward an understanding of the functional complexity of the E2F and retinoblastoma families.
Cell Growth Differ.
9:585-593[Medline].
|
| 46.
|
Ng, H. H.,
Y. Zhang,
B. Hendrich,
C. A. Johnson,
B. M. Turner,
H. Erdjument-Bromage,
P. Tempst,
D. Reinberg, and A. Bird.
1999.
MBD2 is a transcriptional repressor belonging to the MeCP1 histone deacetylase complex.
Nat. Genet.
23:58-61[Medline].
|
| 47.
|
Ohtani, K.,
J. DeGregori, and J. R. Nevins.
1995.
Regulation of the cyclin E gene by transcription factor E2F1.
Proc. Natl. Acad. Sci. USA
92:12146-2150[Abstract/Free Full Text].
|
| 48.
|
Otterson, G. A.,
R. A. Kratzke,
A. Y. Lin,
P. G. Johnston, and F. J. Kaye.
1993.
Alternative splicing of the RBP1 gene clusters in an internal exon that encodes potential phosphorylation sites.
Oncogene
8:949-957[Medline].
|
| 49.
|
Qian, Y. W.,
Y. C. Wang,
R. J. Hollingsworth,
D. Jones,
N. Ling, and E. Y. Lee.
1993.
A retinoblastoma-binding protein related to a negative regulator of Ras in yeast.
Nature
364:648-652[CrossRef][Medline].
|
| 50.
|
Ross, J. F.,
X. Liu, and B. D. Dynlacht.
1999.
Mechanism of transcriptional repression of E2F by the retinoblastoma tumor suppressor protein.
Mol. Cell
3:195-205[CrossRef][Medline].
|
| 51.
|
Rundlett, S. E.,
A. A. Carmen,
R. Kobayashi,
S. Bavykin,
B. M. Turner, and M. Grunstein.
1996.
HDA1 and RPD3 are members of distinct yeast histone deacetylase complexes that regulate silencing and transcription.
Proc. Natl. Acad. Sci. USA
93:14503-14508[Abstract/Free Full Text].
|
| 52.
|
Sellers, W. R.,
J. W. Rodgers, and W. G. J. Kaelin.
1995.
A potent transrepression domain in the retinoblastoma protein induces a cell cycle arrest when bound to E2F sites.
Proc. Natl. Acad. Sci. USA
92:11544-11548[Abstract/Free Full Text].
|
| 53.
|
Struhl, K.
1999.
Fundamentally different logic of gene regulation in eukaryotes and prokaryotes.
Cell
98:1-4[CrossRef][Medline].
|
| 54.
|
Sun, Z. W., and M. Hampsey.
1999.
A general requirement for the Sin3-Rpd3 histone deacetylase complex in regulating silencing in Saccharomyces cerevisiae.
Genetics
152:921-932[Abstract/Free Full Text].
|
| 55.
|
Taunton, J.,
C. A. Hassig, and S. L. Schreiber.
1996.
A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3p.
Science
272:408-411[Abstract].
|
| 56.
|
Tokitou, F.,
T. Nomura,
M. M. Khan,
S. C. Kaul,
R. Wadhwa,
T. Yasukawa,
I. Kohno, and S. Ishii.
1999.
Viral ski inhibits retinoblastoma protein (Rb)-mediated transcriptional repression in a dominant negative fashion.
J. Biol. Chem.
274:4485-4458[Abstract/Free Full Text].
|
| 57.
|
Trouche, D.,
C. Le Chalony,
C. Muchardt,
M. Yaniv, and T. Kouzarides.
1997.
RB and hbrm cooperate to repress the activation functions of E2F1.
Proc. Natl. Acad. Sci. USA
94:11268-11273[Abstract/Free Full Text].
|
| 58.
|
Wade, P. A.,
A. Gegonne,
P. L. Jones,
E. Ballestar,
F. Aubry, and A. P. Wolffe.
1999.
Mi-2 complex couples DNA methylation to chromatin remodelling and histone deacetylation.
Nat. Genet.
23:62-66[Medline].
|
| 59.
|
Wade, P. A.,
P. L. Jones,
D. Vermaak, and A. P. Wolffe.
1998.
A multiple subunit Mi-2 histone deacetylase from Xenopus laevis cofractionates with an associated Snf2 superfamily ATPase.
Curr. Biol.
8:843-846[CrossRef][Medline].
|
| 60.
|
Wang, A. H.,
N. R. Bertos,
M. Vezmar,
N. Pelletier,
M. Crosato,
H. H. Heng,
J. Th'ng,
J. Han, and X. J. Yang.
1999.
HDAC4, a human histone deacetylase related to yeast HDA1, is a transcriptional corepressor.
Mol. Cell. Biol.
19:7816-7827[Abstract/Free Full Text].
|
| 61.
|
Weintraub, S. J.,
C. A. Prater, and D. C. Dean.
1992.
Retinoblastoma protein switches the E2F site from positive to negative element.
Nature
358:259-261[CrossRef][Medline].
|
| 62.
|
Weintraub, S. J.,
K. N. Chow,
R. X. Luo,
S. H. Zhang,
S. He, and D. C. Dean.
1995.
Mechanism of active transcriptional repression by the retinoblastoma protein.
Nature
375:812-815[CrossRef][Medline].
|
| 63.
|
Welch, P. J., and J. Y. Wang.
1993.
A C-terminal protein-binding domain in the retinoblastoma protein regulates nuclear c-Abl tyrosine kinase in the cell cycle.
Indian J. Pediatr.
60:193-201[Medline].
|
| 64.
|
Xue, Y.,
J. Wong,
G. T. Moreno,
M. K. Young,
J. Cote, and W. Wang.
1998.
NURD, a novel complex with both ATP-dependent chromatin-remodeling and histone deacetylase activities.
Mol. Cell
2:851-861[CrossRef][Medline].
|
| 65.
|
Yang, W. M.,
C. Inouye,
Y. Zeng,
D. Bearss, and E. Seto.
1996.
Transcriptional repression by YY1 is mediated by interaction with a mammalian homolog of the yeast global regulator RPD3.
Proc. Natl. Acad. Sci. USA
93:12845-12850[Abstract/Free Full Text].
|
| 66.
|
Yang, W. M.,
Y. L. Yao,
J. M. Sun,
J. R. Davie, and E. Seto.
1997.
Isolation and characterization of cDNAs corresponding to an additional member of the human histone deacetylase gene family.
J. Biol. Chem.
272:28001-28007[Abstract/Free Full Text].
|
| 67.
|
Zhang, S. H.,
A. A. Postigo, and D. C. Dean.
1999.
Active transcriptional repression by the Rb-E2F complex mediates G1 arrest triggered by p16INK4A, TGF- , and contact inhibition.
Cell
97:53-61[CrossRef][Medline].
|
| 68.
|
Zhang, Y.,
G. LeRoy,
H. P. Seelig,
W. S. Lane, and D. Reinberg.
1998.
The dermatomyositis-specific autoantigen Mi2 is a component of a complex containing histone deacetylase and nucleosome remodeling activities.
Cell
95:279-289[CrossRef][Medline].
|
| 69.
|
Zhang, Y.,
H. H. Ng,
H. Erdjument-Bromage,
P. Tempst,
A. Bird, and D. Reinberg.
1999.
Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation.
Genes Dev.
13:1924-1935[Abstract/Free Full Text].
|
| 70.
|
Zhang, Y.,
R. Iratni,
H. Erdjument-Bromage,
P. Tempst, and D. Reinberg.
1997.
Histone deacetylases and SAP18, a novel polypeptide, are components of a human Sin3 complex.
Cell
89:357-364[CrossRef][Medline].
|
| 71.
|
Zhang, Y.,
Z. W. Sun,
R. Iratni,
H. Erdjument-Bromage,
P. Tempst,
M. Hampsey, and D. Reinberg.
1998.
SAP30, a novel protein conserved between human and yeast, is a component of a histone deacetylase complex.
Mol. Cell
1:1021-1031[CrossRef][Medline].
|
Molecular and Cellular Biology, April 2001, p. 2918-2932, Vol. 21, No. 8
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.21.8.2918-2932.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Francis, S. M., Bergsied, J., Isaac, C. E., Coschi, C. H., Martens, A. L., Hojilla, C. V., Chakrabarti, S., DiMattia, G. E., Khoka, R., Wang, J. Y. J., Dick, F. A.
(2009). A Functional Connection between pRB and Transforming Growth Factor {beta} in Growth Inhibition and Mammary Gland Development. Mol. Cell. Biol.
29: 4455-4466
[Abstract]
[Full Text]
-
Stengel, K. R., Thangavel, C., Solomon, D. A., Angus, S. P., Zheng, Y., Knudsen, E. S.
(2009). Retinoblastoma/p107/p130 Pocket Proteins: PROTEIN DYNAMICS AND INTERACTIONS WITH TARGET GENE PROMOTERS. J. Biol. Chem.
284: 19265-19271
[Abstract]
[Full Text]
-
He, Y., Imhoff, R., Sahu, A., Radhakrishnan, I.
(2009). Solution structure of a novel zinc finger motif in the SAP30 polypeptide of the Sin3 corepressor complex and its potential role in nucleic acid recognition. Nucleic Acids Res
37: 2142-2152
[Abstract]
[Full Text]
-
Viiri, K. M., Janis, J., Siggers, T., Heinonen, T. Y. K., Valjakka, J., Bulyk, M. L., Maki, M., Lohi, O.
(2009). DNA-Binding and -Bending Activities of SAP30L and SAP30 Are Mediated by a Zinc-Dependent Module and Monophosphoinositides. Mol. Cell. Biol.
29: 342-356
[Abstract]
[Full Text]
-
Wu, M.-Y., Eldin, K. W., Beaudet, A. L.
(2008). Identification of Chromatin Remodeling Genes Arid4a and Arid4b as Leukemia Suppressor Genes. JNCI J Natl Cancer Inst
100: 1247-1259
[Abstract]
[Full Text]
-
Cheng, J., Kydd, A. R., Nakase, K., Noonan, K. M., Murakami, A., Tao, H., Dwyer, M., Xu, C., Zhu, Q., Marasco, W. A.
(2007). Negative regulation of the SH2-homology containing protein-tyrosine phosphatase-1 (SHP-1) P2 promoter by the HTLV-1 Tax oncoprotein. Blood
110: 2110-2120
[Abstract]
[Full Text]
-
Landis, M. W., Brown, N. E., Baker, G. L., Shifrin, A., Das, M., Geng, Y., Sicinski, P., Hinds, P. W.
(2007). The LxCxE pRb Interaction Domain of Cyclin D1 Is Dispensable for Murine Development. Cancer Res.
67: 7613-7620
[Abstract]
[Full Text]
-
Gunawardena, R. W., Fox, S. R., Siddiqui, H., Knudsen, E. S.
(2007). SWI/SNF Activity Is Required for the Repression of Deoxyribonucleotide Triphosphate Metabolic Enzymes via the Recruitment of mSin3B. J. Biol. Chem.
282: 20116-20123
[Abstract]
[Full Text]
-
Wu, M.-Y., Tsai, T.-F., Beaudet, A. L.
(2006). Deficiency of Rbbp1/Arid4a and Rbbp1l1/Arid4b alters epigenetic modifications and suppresses an imprinting defect in the PWS/AS domain.. Genes Dev.
20: 2859-2870
[Abstract]
[Full Text]
-
Viiri, K. M., Korkeamaki, H., Kukkonen, M. K., Nieminen, L. K., Lindfors, K., Peterson, P., Maki, M., Kainulainen, H., Lohi, O.
(2006). SAP30L interacts with members of the Sin3A corepressor complex and targets Sin3A to the nucleolus. Nucleic Acids Res
34: 3288-3298
[Abstract]
[Full Text]
-
MacWilliams, H., Doquang, K., Pedrola, R., Dollman, G., Grassi, D., Peis, T., Tsang, A., Ceccarelli, A.
(2006). A retinoblastoma ortholog controls stalk/spore preference in Dictyostelium. Development
133: 1287-1297
[Abstract]
[Full Text]
-
Binda, O., Roy, J.-S., Branton, P. E.
(2006). RBP1 Family Proteins Exhibit SUMOylation-Dependent Transcriptional Repression and Induce Cell Growth Inhibition Reminiscent of Senescence.. Mol. Cell. Biol.
26: 1917-1931
[Abstract]
[Full Text]
-
Colina, A. R., Young, D.
(2005). Raf60, a Novel Component of the Rpd3 Histone Deacetylase Complex Required for Rpd3 Activity in Saccharomyces cerevisiae. J. Biol. Chem.
280: 42552-42556
[Abstract]
[Full Text]
-
Zhang, Y., Akinmade, D., Hamburger, A. W.
(2005). The ErbB3 binding protein Ebp1 interacts with Sin3A to repress E2F1 and AR-mediated transcription. Nucleic Acids Res
33: 6024-6033
[Abstract]
[Full Text]
-
Cowley, S. M., Iritani, B. M., Mendrysa, S. M., Xu, T., Cheng, P. F., Yada, J., Liggitt, H. D., Eisenman, R. N.
(2005). The mSin3A Chromatin-Modifying Complex Is Essential for Embryogenesis and T-Cell Development. Mol. Cell. Biol.
25: 6990-7004
[Abstract]
[Full Text]
-
Gray, S. G., Iglesias, A. H., Lizcano, F., Villanueva, R., Camelo, S., Jingu, H., Teh, B. T., Koibuchi, N., Chin, W. W., Kokkotou, E., Dangond, F.
(2005). Functional Characterization of JMJD2A, a Histone Deacetylase- and Retinoblastoma-binding Protein. J. Biol. Chem.
280: 28507-28518
[Abstract]
[Full Text]
-
Yaari, S., Jacob-Hirsch, J., Amariglio, N., Haklai, R., Rechavi, G., Kloog, Y.
(2005). Disruption of Cooperation Between Ras and MycN in Human Neuroblastoma Cells Promotes Growth Arrest. Clin. Cancer Res.
11: 4321-4330
[Abstract]
[Full Text]
-
Patsialou, A., Wilsker, D., Moran, E.
(2005). DNA-binding properties of ARID family proteins. Nucleic Acids Res
33: 66-80
[Abstract]
[Full Text]
-
Taylor-Harding, B., Binne, U. K., Korenjak, M., Brehm, A., Dyson, N. J.
(2004). p55, the Drosophila Ortholog of RbAp46/RbAp48, Is Required for the Repression of dE2F2/RBF-Regulated Genes. Mol. Cell. Biol.
24: 9124-9136
[Abstract]
[Full Text]
-
Cui, D., Jin, G., Gao, T., Sun, T., Tian, F., Estrada, G. G., Gao, H., Sarai, A.
(2004). Characterization of BRCAA1 and Its Novel Antigen Epitope Identification. Cancer Epidemiol. Biomarkers Prev.
13: 1136-1145
[Abstract]
[Full Text]
-
Johnson, B. R., Nitta, R. T., Frock, R. L., Mounkes, L., Barbie, D. A., Stewart, C. L., Harlow, E., Kennedy, B. K.
(2004). A-type lamins regulate retinoblastoma protein function by promoting subnuclear localization and preventing proteasomal degradation. Proc. Natl. Acad. Sci. USA
101: 9677-9682
[Abstract]
[Full Text]
-
Le Guezennec, X., Vriend, G., Stunnenberg, H. G.
(2004). Molecular Determinants of the Interaction of Mad with the PAH2 Domain of mSin3. J. Biol. Chem.
279: 25823-25829
[Abstract]
[Full Text]
-
Pennaneach, V., Barbier, V., Regazzoni, K., Fotedar, R., Fotedar, A.
(2004). Rb Inhibits E2F-1-induced Cell Death in a LXCXE-dependent Manner by Active Repression. J. Biol. Chem.
279: 23376-23383
[Abstract]
[Full Text]
-
Frolov, M. V., Dyson, N. J.
(2004). Molecular mechanisms of E2F-dependent activation and pRB-mediated repression. J. Cell Sci.
117: 2173-2181
[Abstract]
[Full Text]
-
Cowley, S. M., Kang, R. S., Frangioni, J. V., Yada, J. J., DeGrand, A. M., Radhakrishnan, I., Eisenman, R. N.
(2004). Functional Analysis of the Mad1-mSin3A Repressor-Corepressor Interaction Reveals Determinants of Specificity, Affinity, and Transcriptional Response. Mol. Cell. Biol.
24: 2698-2709
[Abstract]
[Full Text]
-
Barbie, D. A., Kudlow, B. A., Frock, R., Zhao, J., Johnson, B. R., Dyson, N., Harlow, E., Kennedy, B. K.
(2004). Nuclear Reorganization of Mammalian DNA Synthesis Prior to Cell Cycle Exit. Mol. Cell. Biol.
24: 595-607
[Abstract]
[Full Text]
-
Meehan, W. J., Samant, R. S., Hopper, J. E., Carrozza, M. J., Shevde, L. A., Workman, J. L., Eckert, K. A., Verderame, M. F., Welch, D. R.
(2004). Breast Cancer Metastasis Suppressor 1 (BRMS1) Forms Complexes with Retinoblastoma-binding Protein 1 (RBP1) and the mSin3 Histone Deacetylase Complex and Represses Transcription. J. Biol. Chem.
279: 1562-1569
[Abstract]
[Full Text]
-
Tominaga, K., Leung, J. K., Rookard, P., Echigo, J., Smith, J. R., Pereira-Smith, O. M.
(2003). MRGX Is a Novel Transcriptional Regulator That Exhibits Activation or Repression of the B-myb Promoter in a Cell Type-dependent Manner. J. Biol. Chem.
278: 49618-49624
[Abstract]
[Full Text]
-
Fleischer, T. C., Yun, U. J., Ayer, D. E.
(2003). Identification and Characterization of Three New Components of the mSin3A Corepressor Complex. Mol. Cell. Biol.
23: 3456-3467
[Abstract]
[Full Text]
-
Baek, S. H., Kioussi, C., Briata, P., Wang, D., Nguyen, H. D., Ohgi, K. A., Glass, C. K., Wynshaw-Boris, A., Rose, D. W., Rosenfeld, M. G.
(2003). Regulated subset of G1 growth-control genes in response to derepression by the Wnt pathway. Proc. Natl. Acad. Sci. USA
100: 3245-3250
[Abstract]
[Full Text]
-
Yochum, G. S., Ayer, D. E.
(2002). Role for the Mortality Factors MORF4, MRGX, and MRG15 in Transcriptional Repression via Associations with Pf1, mSin3A, and Transducin-Like Enhancer of Split. Mol. Cell. Biol.
22: 7868-7876
[Abstract]
[Full Text]
-
Markey, M. P., Angus, S. P., Strobeck, M. W., Williams, S. L., Gunawardena, R. W., Aronow, B. J., Knudsen, E. S.
(2002). Unbiased Analysis of RB-mediated Transcriptional Repression Identifies Novel Targets and Distinctions from E2F Action. Cancer Res.
62: 6587-6597
[Abstract]
[Full Text]
-
Xie, A.-Y., Folk, W. R.
(2002). Inhibition of Polyomavirus ori-Dependent DNA Replication by mSin3B. J. Virol.
76: 11809-11818
[Abstract]
[Full Text]
-
Hook, S. S., Orian, A., Cowley, S. M., Eisenman, R. N.
(2002). Histone deacetylase 6 binds polyubiquitin through its zinc finger (PAZ domain) and copurifies with deubiquitinating enzymes. Proc. Natl. Acad. Sci. USA
99: 13425-13430
[Abstract]
[Full Text]
-
Reilly, P. T., Wysocka, J., Herr, W.
(2002). Inactivation of the Retinoblastoma Protein Family Can Bypass the HCF-1 Defect in tsBN67 Cell Proliferation and Cytokinesis. Mol. Cell. Biol.
22: 6767-6778
[Abstract]
[Full Text]
-
Sun, J.-M., Chen, H. Y., Moniwa, M., Litchfield, D. W., Seto, E., Davie, J. R.
(2002). The Transcriptional Repressor Sp3 Is Associated with CK2-phosphorylated Histone Deacetylase 2. J. Biol. Chem.
277: 35783-35786
[Abstract]
[Full Text]
-
Rayman, J. B., Takahashi, Y., Indjeian, V. B., Dannenberg, J.-H., Catchpole, S., Watson, R. J., te Riele, H., Dynlacht, B. D.
(2002). E2F mediates cell cycle-dependent transcriptional repression in vivo by recruitment of an HDAC1/mSin3B corepressor complex. Genes Dev.
16: 933-947
[Abstract]
[Full Text]
-
Wilsker, D., Patsialou, A., Dallas, P. B., Moran, E.
(2002). ARID Proteins: A Diverse Family of DNA Binding Proteins Implicated in the Control of Cell Growth, Differentiation, and Development. Cell Growth Differ.
13: 95-106
[Abstract]
[Full Text]
-
Kuzmichev, A., Zhang, Y., Erdjument-Bromage, H., Tempst, P., Reinberg, D.
(2002). Role of the Sin3-Histone Deacetylase Complex in Growth Regulation by the Candidate Tumor Suppressor p33ING1. Mol. Cell. Biol.
22: 835-848
[Abstract]
[Full Text]
-
Cao, J.-n., Gao, T.-w., Stanbridge, E. J., Irie, R.
(2001). RBP1L1, a Retinoblastoma-Binding Protein-Related Gene Encoding an Antigenic Epitope Abundantly Expressed in Human Carcinomas and Normal Testis. JNCI J Natl Cancer Inst
93: 1159-1165
[Abstract]
[Full Text]
-
Kennedy, B. K., Liu, O. W., Dick, F. A., Dyson, N., Harlow, E., Vidal, M.
(2001). Histone deacetylase-dependent transcriptional repression by pRB in yeast occurs independently of interaction through the LXCXE binding cleft. Proc. Natl. Acad. Sci. USA
10.1073/pnas.151240898v1
[Abstract]
[Full Text]
-
Kennedy, B. K., Liu, O. W., Dick, F. A., Dyson, N., Harlow, E., Vidal, M.
(2001). Histone deacetylase-dependent transcriptional repression by pRB in yeast occurs independently of interaction through the LXCXE binding cleft. Proc. Natl. Acad. Sci. USA
98: 8720-8725
[Abstract]
[Full Text]